Molecular Devices 3D biology portfolio
31 July, 2023Molecular Devices' robust portfolio of end-to-end high-throughput solutions, user-friendly AI-powered data analysis and committed 3D biotechnology investments should support users in overcoming all their 3D biology challenges.
Pharmacists develop a cheeky solution for drug delivery
20 July, 2023Researchers have developed a novel oral film that discreetly releases drugs into the bloodstream via the mucosal membrane — the moist, inner lining of the mouth.
FDA approves gout medication to treat heart disease
18 July, 2023Colchicine, a widely available gout medication, has been approved by the FDA to be used in low doses to prevent cardiovascular events in patients with coronary disease.
Medigrowth and Deakin Uni partner on medicinal cannabis centre
13 July, 2023Medigrowth, a fully licensed Australian medicinal cannabis biotech, has announced plans to build a Centre of Excellence in Geelong in partnership with Deakin University.
New generic cancer treatment spares healthy tissue
05 July, 2023Scientists utilised a compound that is designed to emit small amounts of alpha radiation from the inside of cancer cells, thus killing them but sparing healthy tissue.
Wanted: biotech ventures to join Jumar Bioincubator
05 July, 2023Australia's latest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its new facility in the Melbourne Biomedical Precinct.
Peptide drug could treat long COVID, prevent reinfection
03 July, 2023A new study shows that the drug prevents inflammation and even repairs damaged lung tissue in preclinical models, making it both a prevention and a treatment.
Stem cell-based regenerative therapy to treat heart failure
30 June, 2023A new study saw pluripotent (immature) stem cells cultivated in the laboratory to grow into heart muscle precursor cells, which can develop into various types of heart cells.
Selective targeting of cancer cells in new treatment approach
26 June, 2023Finding a way to make drugs act more selectively on cancer cells is the key to improving treatment success while reducing toxicity in children treated for high-risk leukaemia.
Needle-free vaccine patch facility opens in Brisbane
26 June, 2023The custom-built, 5500 m2 Vaxxas Biomedical Facility will support the production of needle-free vaccine patches for future late-stage clinical trials and commercial products.
Personalised vaccines trialled for skin cancer treatment
16 June, 2023An mRNA vaccine tailored to suit an individual's tumour genetics was added to common immunotherapy treatment, with promising results.
UQ partners with US university to create homegrown vaccines
08 June, 2023The University of Queensland and Emory University have committed to scaling up their collaboration to focus on pandemic preparedness and regional disease prevention.
Oral medication for Crohn's disease approved by FDA
07 June, 2023Patients with moderate-to-severe Crohn's disease now have a new treatment option to suppress their intestinal inflammation and help them maintain their relief.
Nanoparticle used to deliver brain cancer drug
05 June, 2023The new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as glioblastoma.
Sydney Uni spinout lands deal to develop psychiatric drugs
10 May, 2023Kinoxis Therapeutics has announced a strategic partnership with Boehringer Ingelheim for the development of first-in-class oxytocin-targeting precision psychiatry treatments.
